---
layout: default
title: Valid Property-Enhanced Contrastive Learning for Targeted Optimization & Resampling for Novel Drug Design
---

# Valid Property-Enhanced Contrastive Learning for Targeted Optimization & Resampling for Novel Drug Design

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2509.00684" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2509.00684v1</a>
  <a href="https://arxiv.org/pdf/2509.00684.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2509.00684v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2509.00684v1', 'Valid Property-Enhanced Contrastive Learning for Targeted Optimization & Resampling for Novel Drug Design')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Amartya Banerjee, Somnath Kar, Anirban Pal, Debabrata Maiti

**åˆ†ç±»**: cs.LG, cs.AI

**å‘å¸ƒæ—¥æœŸ**: 2025-08-31

**å¤‡æ³¨**: Code: https://github.com/amartya21/vector-drug-design.git

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºVECTOR+ä»¥è§£å†³ä½æ•°æ®ç¯å¢ƒä¸‹è¯ç‰©è®¾è®¡é—®é¢˜**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±äºŒï¼šRLç®—æ³•ä¸æ¶æ„ (RL & Architecture)**

**å…³é”®è¯**: `è¯ç‰©è®¾è®¡` `ç”Ÿæˆæ¨¡å‹` `å¯¹æ¯”å­¦ä¹ ` `åŒ–å­¦ç©ºé—´` `ä½æ•°æ®ç¯å¢ƒ` `åˆ†å­ç”Ÿæˆ` `è¯ç†ç›¸å…³æ€§` `æ–°è¯å‘ç°`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰è¯ç‰©è®¾è®¡æ–¹æ³•åœ¨ä½æ•°æ®ç¯å¢ƒä¸‹éš¾ä»¥æœ‰æ•ˆæ¢ç´¢è¯ç†ç›¸å…³çš„åŒ–å­¦ç©ºé—´ï¼Œé™åˆ¶äº†æ–°è¯çš„å‘ç°ã€‚
2. VECTOR+æ¡†æ¶é€šè¿‡ç»“åˆå±æ€§å¼•å¯¼çš„å¯¹æ¯”å­¦ä¹ ä¸åˆ†å­ç”Ÿæˆï¼Œå®ç°äº†å¯æ§çš„åˆ†å­è®¾è®¡ä¸ä¼˜åŒ–ã€‚
3. åœ¨PD-L1å’Œæ¿€é…¶æŠ‘åˆ¶å‰‚æ•°æ®é›†ä¸Šï¼ŒVECTOR+ç”Ÿæˆçš„åˆ†å­åœ¨å¯¹æ¥è¯„åˆ†ä¸Šè¶…è¿‡äº†ç°æœ‰è¯ç‰©ï¼Œæ˜¾ç¤ºå‡ºæ˜¾è‘—çš„æ€§èƒ½æå‡ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

åœ¨è¯ç‰©å‘ç°è¿‡ç¨‹ä¸­ï¼Œæœ‰æ•ˆå¼•å¯¼ç”Ÿæˆæ¨¡å‹æœå‘è¯ç†ç›¸å…³çš„åŒ–å­¦ç©ºé—´ä»ç„¶æ˜¯ä¸€ä¸ªä¸»è¦æŒ‘æˆ˜ï¼Œå°¤å…¶æ˜¯åœ¨æ•°æ®ç¨€ç¼ºçš„æƒ…å†µä¸‹ã€‚æœ¬æ–‡æå‡ºäº†VECTOR+æ¡†æ¶ï¼Œç»“åˆäº†åŸºäºå±æ€§çš„è¡¨ç¤ºå­¦ä¹ ä¸å¯æ§çš„åˆ†å­ç”Ÿæˆï¼Œé€‚ç”¨äºå›å½’å’Œåˆ†ç±»ä»»åŠ¡ï¼Œèƒ½å¤Ÿå®ç°å¯¹åŠŸèƒ½åŒ–å­¦ç©ºé—´çš„å¯è§£é‡Šä¸”æ•°æ®é«˜æ•ˆçš„æ¢ç´¢ã€‚åœ¨ä¸¤ä¸ªæ•°æ®é›†ä¸Šè¿›è¡Œè¯„ä¼°ï¼ŒVECTOR+ç”Ÿæˆäº†æ–°é¢–ä¸”åˆæˆå¯è¡Œçš„å€™é€‰åˆ†å­ï¼Œè¡¨ç°å‡ºä¼˜è¶Šçš„æ€§èƒ½ã€‚å®éªŒç»“æœè¡¨æ˜ï¼ŒVECTOR+åœ¨è¯ç‰©è®¾è®¡ä¸­å…·æœ‰å¹¿æ³›çš„åº”ç”¨æ½œåŠ›ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæœ¬æ–‡æ—¨åœ¨è§£å†³åœ¨ä½æ•°æ®ç¯å¢ƒä¸‹è¯ç‰©è®¾è®¡ä¸­ï¼Œå¦‚ä½•æœ‰æ•ˆå¼•å¯¼ç”Ÿæˆæ¨¡å‹æ¢ç´¢è¯ç†ç›¸å…³çš„åŒ–å­¦ç©ºé—´çš„é—®é¢˜ã€‚ç°æœ‰æ–¹æ³•åœ¨æ•°æ®ç¨€ç¼ºæ—¶è¡¨ç°ä¸ä½³ï¼Œå¯¼è‡´ç”Ÿæˆçš„å€™é€‰åˆ†å­è´¨é‡ä½ä¸‹ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šVECTOR+æ¡†æ¶é€šè¿‡å¼•å…¥æœ‰æ•ˆå±æ€§å¼•å¯¼çš„å¯¹æ¯”å­¦ä¹ ï¼Œç»“åˆå¯æ§çš„åˆ†å­ç”Ÿæˆï¼Œæ—¨åœ¨æé«˜ç”Ÿæˆåˆ†å­çš„è´¨é‡å’Œç›¸å…³æ€§ã€‚è¿™æ ·çš„è®¾è®¡ä½¿å¾—æ¨¡å‹èƒ½å¤Ÿåœ¨æœ‰é™çš„æ•°æ®ä¸Šè¿›è¡Œæœ‰æ•ˆçš„å­¦ä¹ å’Œä¼˜åŒ–ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šVECTOR+çš„æ•´ä½“æ¶æ„åŒ…æ‹¬å±æ€§å¼•å¯¼çš„è¡¨ç¤ºå­¦ä¹ æ¨¡å—å’Œåˆ†å­ç”Ÿæˆæ¨¡å—ã€‚é¦–å…ˆï¼Œé€šè¿‡å¯¹æ¯”å­¦ä¹ è·å–åˆ†å­çš„æœ‰æ•ˆè¡¨ç¤ºï¼Œç„¶ååˆ©ç”¨è¿™äº›è¡¨ç¤ºè¿›è¡Œåˆ†å­çš„ç”Ÿæˆå’Œä¼˜åŒ–ã€‚

**å…³é”®åˆ›æ–°**ï¼šVECTOR+çš„ä¸»è¦åˆ›æ–°åœ¨äºå°†å¯¹æ¯”å­¦ä¹ ä¸ç”Ÿæˆæ¨¡å‹ç›¸ç»“åˆï¼Œå½¢æˆäº†ä¸€ç§æ–°çš„å±æ€§æ¡ä»¶åˆ†å­è®¾è®¡æ–¹æ³•ã€‚è¿™ç§æ–¹æ³•åœ¨ä½æ•°æ®ç¯å¢ƒä¸‹è¡¨ç°å‡ºè‰²ï¼Œæ˜¾è‘—æé«˜äº†ç”Ÿæˆåˆ†å­çš„è¯ç†ç›¸å…³æ€§ã€‚

**å…³é”®è®¾è®¡**ï¼šåœ¨æ¨¡å‹è®¾è®¡ä¸­ï¼ŒVECTOR+é‡‡ç”¨äº†ç‰¹å®šçš„æŸå¤±å‡½æ•°ä»¥å¼ºåŒ–å±æ€§å¼•å¯¼çš„å­¦ä¹ ï¼ŒåŒæ—¶åœ¨ç½‘ç»œç»“æ„ä¸Šè¿›è¡Œäº†ä¼˜åŒ–ï¼Œä»¥ç¡®ä¿ç”Ÿæˆåˆ†å­çš„åˆæˆå¯è¡Œæ€§å’Œè¯ç†æ´»æ€§ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

åœ¨PD-L1æŠ‘åˆ¶å‰‚çš„å®éªŒä¸­ï¼ŒVECTOR+ç”Ÿæˆçš„8,374ä¸ªåˆ†å­ä¸­ï¼Œæœ‰100ä¸ªåˆ†å­çš„å¯¹æ¥è¯„åˆ†è¶…è¿‡äº†-15.0 kcal/molï¼Œæœ€ä½³åˆ†å­è¯„åˆ†ä¸º-17.6 kcal/molï¼Œä¼˜äºå‚è€ƒæŠ‘åˆ¶å‰‚çš„-15.4 kcal/molã€‚æ­¤å¤–ï¼ŒVECTOR+åœ¨æ¿€é…¶æŠ‘åˆ¶å‰‚çš„ç”Ÿæˆä¸­ä¹Ÿè¡¨ç°å‡ºè‰²ï¼Œç”Ÿæˆçš„åˆ†å­å¯¹æ¥è¯„åˆ†è¶…è¿‡äº†ç°æœ‰è¯ç‰©å¦‚brigatinibå’Œsorafenibã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶çš„æ½œåœ¨åº”ç”¨é¢†åŸŸåŒ…æ‹¬æ–°è¯å‘ç°ã€åŒ–å­¦åˆæˆå’Œç”Ÿç‰©åŒ»è¯ç­‰ã€‚é€šè¿‡æé«˜è¯ç‰©è®¾è®¡çš„æ•ˆç‡å’Œå‡†ç¡®æ€§ï¼ŒVECTOR+æœ‰æœ›åŠ é€Ÿæ–°è¯çš„ç ”å‘è¿›ç¨‹ï¼Œé™ä½ç ”å‘æˆæœ¬ï¼Œå¹¶æ¨åŠ¨ä¸ªæ€§åŒ–åŒ»ç–—çš„å‘å±•ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Efficiently steering generative models toward pharmacologically relevant regions of chemical space remains a major obstacle in molecular drug discovery under low-data regimes. We present VECTOR+: Valid-property-Enhanced Contrastive Learning for Targeted Optimization and Resampling, a framework that couples property-guided representation learning with controllable molecule generation. VECTOR+ applies to both regression and classification tasks and enables interpretable, data-efficient exploration of functional chemical space. We evaluate on two datasets: a curated PD-L1 inhibitor set (296 compounds with experimental $IC_{50}$ values) and a receptor kinase inhibitor set (2,056 molecules by binding mode). Despite limited training data, VECTOR+ generates novel, synthetically tractable candidates. Against PD-L1 (PDB 5J89), 100 of 8,374 generated molecules surpass a docking threshold of $-15.0$ kcal/mol, with the best scoring $-17.6$ kcal/mol compared to the top reference inhibitor ($-15.4$ kcal/mol). The best-performing molecules retain the conserved biphenyl pharmacophore while introducing novel motifs. Molecular dynamics (250 ns) confirm binding stability (ligand RMSD < $2.5$ angstroms). VECTOR+ generalizes to kinase inhibitors, producing compounds with stronger docking scores than established drugs such as brigatinib and sorafenib. Benchmarking against JT-VAE and MolGPT across docking, novelty, uniqueness, and Tanimoto similarity highlights the superior performance of our method. These results position our work as a robust, extensible approach for property-conditioned molecular design in low-data settings, bridging contrastive learning and generative modeling for reproducible, AI-accelerated discovery.

